Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS InhibitorsMatthew R. Weir, Bertram Pitt, George L. Bakris et al.|New England Journal of Medicine|2014Cited by 658
MYH9 is associated with nondiabetic end-stage renal disease in African AmericansW.H. Linda Kao, Rulan S. Parekh, Michael J. Klag et al.|Nature Genetics|2008Cited by 648
Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled HypertensionLuke J. Laffin, Larkin T. Wadsworth, David Rodman et al.|JAMA|2023Cited by 187
Adherence to Healthy Dietary Patterns and Risk of CKD Progression and All-Cause Mortality: Findings From the CRIC (Chronic Renal Insufficiency Cohort) StudyEmily Hu, Raymond R. Townsend, Josef Coresh et al.|American Journal of Kidney Diseases|2020Cited by 179
Abnormalities of Potassium in Heart FailureJoão Pedro Ferreira, Faı̈ez Zannad, Matthew R. Weir et al.|Journal of the American College of Cardiology|2020Cited by 177